: Representative curves for the chemogram analysis performed on xenograft-derived cells. The continuous line indicates vehicle-treated xenografts, and the discontinuous line shows curves for the gemcitabine-treated xenografts. The chief clinical characteristics of the patients studied and the principal biological information available for these tumors. Table S3 : Expression of CD44-APC, CD24-PE, EpCAM-VioBlue and ALDH-FITC markers in 14 different primary cell lines. Error bars ± SEM; n=3 per group.
